The efficacy and safety of an oral iron chelating agent, deferasirox, for iron overload in a patient with chronic kidney disease and myelodysplastic syndrome

Fukui, S., Torimoto, K., Kagebayashi, Y., Morimoto, K., Yamaguchi, S., Hamano, K., & Samma, S. (2009). The efficacy and safety of an oral iron chelating agent, deferasirox, for iron overload in a patient with chronic kidney disease and myelodysplastic syndrome. Nihon Toseki Igakkai Zasshi, 42(11), 865–869. https://doi.org/10.4009/jsdt.42.865